Gosset Ownership
Private
Employees
~200
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Astrea Fontaine General Information
Astrea Fontaine is an active CDMO specializing in the manufacture of small molecule pharmaceuticals, with capabilities in both oral solid and aseptic dosage forms. The company operates from its site in Fontaine-lès-Dijon, France, which was acquired from Recipharm in early 2022. There is no evidence of proprietary clinical programs or direct drug development activities.
Contact Information
Primary Industry
Contract Manufacturing Organization
Corporate Office
Fontaine-lès-Dijon, Côte-d'Or/Bourgogne-Franche-Comté
France
France
Drug Pipeline
No pipeline data available
Key Partnerships
Astrea Fontaine Funding
No funding data available
To view Astrea Fontaine's complete valuation and funding history, request access »